Stay updated with breaking news from Study Evaluating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Inavolisib in combination with palbociclib and fulvestrant more than doubled progression-free survival compared to palbociclib and fulvestrant alone1The inavolisib combination has the potential to...
Enrollment Complete in Study Evaluating the Performance of the Ringer™ Perfusion Balloon Catheter in Patients Undergoing Percutaneous Coronary InterventionsWAYNE, Pa., July 19, 2023 -- Teleflex...
Find the facts of Portal Hypertension and TIPS including Causes, Symptoms, Diagnosis & Treatment and more information.
20.06.2023 - GOTHENBURG, SE / ACCESSWIRE / June 20, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, June 20, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's ...
IRLAB to Present Data from the Phase IIb Study of Mesdopetam in PD-LIDs ...